| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |